Summary
This observational study from 2021, published in the Journal of the American College of Cardiology, examined the natural history and progression of tricuspid regurgitation in patients treated surgically for ischaemic mitral regurgitation. The research, involving a large multicentre cohort with extensive follow-up data, as suggested by the authorship and journal scope, sought to characterise TR severity trajectories and their association with clinical outcomes post-mitral valve surgery.
Regional applicability
This study was conducted in the United States and addresses cardiothoracic surgical practice and outcomes. Findings are transferable to United Kingdom cardiothoracic units insofar as surgical techniques and patient populations are comparable; however, local clinical outcomes may vary depending on operative experience, post-operative management protocols, and patient case-mix.
Key measures
Tricuspid regurgitation severity grade, left ventricular ejection fraction, right ventricular function, mortality, morbidity, and symptom status assessed via echocardiography and clinical follow-up
Outcomes reported
The study examined the progression of tricuspid regurgitation (TR) in patients undergoing surgical repair for ischaemic mitral regurgitation, tracking TR severity and associated clinical outcomes over time.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.